RxDoctor Payments DataLook up a doctor →

Thomas Taylor, MD

Dermatology · Tampa, FLNPI 1568464931

Payments from drug & device makers

$13,573,799in general payments, 2019–2025

Across 743 payments — averaging $18,269 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$11.2M
  • Janssen Research & Development, LLC$1.1M
  • Vanda Pharmaceuticals Inc.$810K
  • Eli Lilly$150K
  • AbbVie$119K
  • Sanofi US Services Inc.$108K
  • plus $119K from 33 others
$14,328in research payments, 2019–2025

Across 21 payments — averaging $682.27 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Eli Lilly$11K
  • Sanofi US Services Inc.$3K
  • AbbVie$532

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$13,573,799 in reported general payments places this provider in the 95th percentile of 1,147 dermatology providers in Florida.

See all dermatology providers in Florida

Medicare billing

Part B allowed, 2024
$165,281
Medicare patients
407
Services billed
2,715

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other dermatology in Tampa

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →